Fgure 3. Molecular genetic report confirming THS resistance via THRB gene. The diagnosis was explained to the patient and levothyroxine dose was reduced gradually to maintain the lowest dose that is sufficient to prevent symptoms with subsequent follow up to depend on T4 level and the patient symptoms not on TSH level.